Effect of Aficamten versus Metoprolol Monotherapy on Biomarkers in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Trial
Conferences
Lakdawala, N; Garcia-Pavia, P; Maron, M; Masri, A; Merkely, B; Nassif, M; Pena, LP; Barriales-Villa, R; Bilen, O; Burroughs, M; Claggett, B ...
Published in: CIRCULATION
December 23, 2025
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
December 23, 2025
Volume
152
Issue
25
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Lakdawala, N., Garcia-Pavia, P., Maron, M., Masri, A., Merkely, B., Nassif, M., … Januzzi, J. (2025). Effect of Aficamten versus Metoprolol Monotherapy on Biomarkers in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Trial. In CIRCULATION (Vol. 152).
Lakdawala, Neal, Pablo Garcia-Pavia, Martin Maron, Ahmad Masri, Bela Merkely, Michael Nassif, Luisa Pena Pena, et al. “Effect of Aficamten versus Metoprolol Monotherapy on Biomarkers in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Trial.” In CIRCULATION, Vol. 152, 2025.
Lakdawala N, Garcia-Pavia P, Maron M, Masri A, Merkely B, Nassif M, et al. Effect of Aficamten versus Metoprolol Monotherapy on Biomarkers in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Trial. In: CIRCULATION. 2025.
Lakdawala, Neal, et al. “Effect of Aficamten versus Metoprolol Monotherapy on Biomarkers in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Trial.” CIRCULATION, vol. 152, no. 25, 2025.
Lakdawala N, Garcia-Pavia P, Maron M, Masri A, Merkely B, Nassif M, Pena LP, Barriales-Villa R, Bilen O, Burroughs M, Claggett B, Costabel J, Correia E, Dybro A, Elliott P, Kulac I, Lewis G, Mann A, Nair A, Poulsen S, Reant P, Schulze C, Solomon S, Wang A, Sohn R, Berhane I, Heitner S, Jacoby D, Kupfer S, Malik F, Wohltman A, Fifer M, Januzzi J. Effect of Aficamten versus Metoprolol Monotherapy on Biomarkers in Obstructive Hypertrophic Cardiomyopathy: The MAPLE-HCM Trial. CIRCULATION. 2025.
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
December 23, 2025
Volume
152
Issue
25
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology